SIEBERT JOHN M 4
4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Jun 24, 2019
Insider Transaction Report
Form 4
SIEBERT JOHN M
Director
Transactions
- Exercise/Conversion
Director Stock Option (Right to Buy)
2019-06-20−10,000→ 0 totalExercise: $9.13From: 2016-03-03Exp: 2025-03-03→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2019-06-20$9.13/sh+10,000$91,300→ 55,742 total